Brain Cancer | Specialty

Dr. Grimm Discusses Primary Brain Cancer Risk Factors

October 31st 2011

Dr. Grimm from Northwestern University, Feinberg School of Medicine Discusses Brain Cancer Risk Factors

ASCO Highlights: Trials in Progress

August 23rd 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

Trastuzumab and Chemotherapy Prolong Survival in Patients With Breast Cancer and CNS Metastases

July 18th 2011

Treatment with Herceptin, chemotherapy, or surgery extended the lives of patients with HER2-positive MBC following a diagnosis of CNS metastases.

5 Abstracts Offer Snapshot of Immunology Research

July 15th 2011

The field of immunotherapy is brimming with questions that researchers are working to answer, and many of those efforts were on display at the ASCO annual meeting.

Afinitor Halves SEGA Tumor Size in Patients With Tuberous Sclerosis

July 11th 2011

In the phase III EXIST-1 trial, Afinitor reduced the size of SEGAs-benign brain tumors associated with TSC-by ≥50% in one-third of patients.

Rethinking Initial Management of Patients With Brain Metastasis and HER2 Breast Cancer

June 6th 2011

Lapatinib and capecitabine is a reasonable approach in a well-informed patient with brain metastasis and HER2+ breast cancer

Oncology Links From Across the Web for Brain Cancer

May 19th 2011

Links to resource from across the web for brain cancer; includes news briefs, patient education, research and clinical trials

Dendritic Cell Vaccine Promising

May 18th 2011

A dendritic cell vaccine under development may increase median survival time in patients with glioblastoma

FDA Approves Novel Device to Treat Brain Cancer

April 18th 2011

The FDA has approved a novel device that uses electric fields to treat aggressive brain tumors

FDA Panel Backs Experimental Brain Cancer Treatment

March 30th 2011

An FDA panel voted 7 to 3 (2 abstentions) in support of the NovoTTF-100A System

Miles for Hope: Cancer Survivor Works to Raise Awareness and Funding for Brain Tumor Research

March 15th 2011

Bob Gibbs knows the importance of cancer research and the life-saving therapies it creates. The 40-year-old husband and father of 4 would not be alive today without these new discoveries and innovations.

Crisis Averted? Manufacturers Scurry to Meet Demand for Drugs

March 12th 2011

The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care

Medulloblastoma Subtypes Are Different Diseases

March 11th 2011

Medulloblastoma, a malignant brain tumor that most commonly affects children, is not one disease but several, said researchers with St. Jude Children's Hospital in Memphis, Tennessee.

Net Guides: Central Nervous System

March 10th 2011

Useful Online Resources and Clinical Trials for Central Nervous System

Modified Herpes Virus to Be Tested in Sarcoma Patients

March 9th 2011

The FDA has awarded a $600,000 grant for a phase I clinical trial of a genetically reprogrammed herpes simplex virus in young cancer patients with relapsed non-central nervous system (CNS) solid tumors such as sarcomas and neuroblastomas.

Dr. Pearlstone on Technological Challenges

March 8th 2011

Net-Guides: Brain Cancers

March 6th 2011

Useful Online Resources and Clinical Trials for Brain Cancer

John Theurer Cancer Center Opens New Comprehensive Facility

March 4th 2011

The John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey, one of the largest cancer centers in the United States

Avastin Alarm

March 4th 2011

A meta-analysis of randomized controlled trials revealed treatment-related fatalities were 1.5 times higher for combination treatment with Avastin (bevacizumab) and chemotherapy versus chemotherapy alone

Oncology Community Facing Severe Drug Shortages

December 19th 2010

Hospitals, pharmacists, and physicians across the United States are reporting shortages of critical anticancer drugs, including carboplatin, cisplatin, dacarbazine, fludarabine, and cytarabine.